Patent · US Active

Combination therapy for the treatment of diabetes and related conditions

US8513264B2 · kind B2 · utility

35Cited by

97References

21Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Michael Mark · Biberach an der Riß, DE
Peter Eickelmann · Mittelbiberach, DE
Gerd LUIPPOLD · Biberach an der Riß, DE
Leo Thomas · Biberach, DE

Key dates

Filing date	Sep 8, 2009
Grant date	Aug 20, 2013
Priority date	—
Expiry date	Sep 8, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to combinations of DPP-4 inhibitors with GPR119 agonists, as well as to the use of these combinations for treating and/or preventing metabolic diseases, particularly diabetes (especially type 2 diabetes mellitus) and conditions related thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.